DEMİREL ÖĞÜT, N. Et Al. 2022. Ixekizumab treatment in patients with moderate-to-severe plaque psoriasis in a real-world clinical setting. Journal of Cosmetic Dermatology , vol.21, no.11 , 6215-6224.

DEMİREL ÖĞÜT, N., Koç Yıldırım, S., Erbağcı, E., & Hapa, F. A., (2022). Ixekizumab treatment in patients with moderate-to-severe plaque psoriasis in a real-world clinical setting. Journal of Cosmetic Dermatology , vol.21, no.11, 6215-6224.

DEMİREL ÖĞÜT, NESLİHAN Et Al. "Ixekizumab treatment in patients with moderate-to-severe plaque psoriasis in a real-world clinical setting," Journal of Cosmetic Dermatology , vol.21, no.11, 6215-6224, 2022

DEMİREL ÖĞÜT, NESLİHAN D. Et Al. "Ixekizumab treatment in patients with moderate-to-severe plaque psoriasis in a real-world clinical setting." Journal of Cosmetic Dermatology , vol.21, no.11, pp.6215-6224, 2022

DEMİREL ÖĞÜT, N. Et Al. (2022) . "Ixekizumab treatment in patients with moderate-to-severe plaque psoriasis in a real-world clinical setting." Journal of Cosmetic Dermatology , vol.21, no.11, pp.6215-6224.

@article{article, author={NESLİHAN DEMİREL ÖĞÜT Et Al. }, title={Ixekizumab treatment in patients with moderate-to-severe plaque psoriasis in a real-world clinical setting}, journal={Journal of Cosmetic Dermatology}, year=2022, pages={6215-6224} }